A new research paper was published in Volume 16 of Oncotarget on July 9, 2025, titled "A novel anti-human CD25 mAb with ...

A new research paper was published in Volume 16 of Oncotarget on July 9, 2025, titled “A novel anti-human CD25 mAb with ...

I-Mab Presents Positive Givastomig Phase 1b Dose Escalation Data in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers at ESMO GI 2025 ...

A federal judge has ruled that an executive order by President Donald Trump suspending asylum access at the southern border is unlawful.

A federal judge has ruled that an executive order by President Donald Trump suspending asylum access at the southern border is unlawful.

Judge blocks order barring asylum access at border, gives administration two weeks to appeal It throws into doubt one of the key pillars of the president’s plan to crack down on migration at the ...

A judge has blocked an order barring asylum access at the border and gave President Donald Trump's administration two weeks to appeal.

Inmagene Doses First Patient in the ADAPTIVE Phase 2b Trial of IMG-007, a Nondepleting Anti-OX40 mAb with an Extended Half-life, in Patients with Moderate-to-Severe Atopic Dermatitis ...

CBS News Los Angeles A vehicle fire on the southbound lanes of the 710 Freeway in Bell stopped traffic in the early morning on Tuesday, according to officials. Caltrans issued a Sigalert at about ...

TAIPEI and SHANGHAI and SAN FRANCISCO, July 1, 2025 /PRNewswire/ -- HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology and ...

I-Mab undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by law.